
Endo Investor Relations Material
Latest events

Q2 2025
Endo
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Endo Inc
Access all reports
Endo Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic medicines. The company focuses on a range of therapeutic areas, including pain management, urology, and dermatology. It provides prescription medications, specialty pharmaceuticals, and sterile injectables to healthcare providers and patients. The company is headquartered in Malvern, Pennsylvania, and its shares are listed on the NASDAQ.
Key slides for Endo Inc


Q1 2025
Endo Inc


M&A Announcement
Endo Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
NDOI
Country
🇺🇸 United States